CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key benefits
1.3. Key market segments
1.4. Research methodology

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market scope and definition
3.2. Competitive environment analysis

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. Top player positioning, 2016
3.4. Patent analysis, 2010-2018
3.5. Market dynamics

3.5.1. Drivers

3.5.1.1. Technological advancements in Sangers sequencing
3.5.1.2. Surge in applications of Sangers sequencing
3.5.1.3. Increase in genome mapping programs

3.5.2. Restraints

3.5.2.1. Lack of skilled professionals
3.5.2.2. Standardization concerns over sequencing-based diagnostics

3.5.3. Opportunities

3.5.3.1. Cloud computing serves as a potential data management service
3.5.3.2. Lucrative opportunities in the emerging markets

CHAPTER 4: GLOBAL AND REGIONAL SANGERS SEQUENCING SERVICE MARKET SHARE ANALYSIS

4.1. Global Sangers sequencing services market share analysis, 2017
4.2. U.S. Sangers sequencing services market share analysis, 2017
4.3. Europe Sangers sequencing services market share analysis, 2017
4.4. Japan Sangers sequencing services market share analysis, 2017
4.5. China Sangers sequencing services market share analysis, 2017
4.6. India Sangers sequencing services market share analysis, 2017
4.7. South-East Asia Sangers sequencing services market share analysis, 2017
4.8. Rest of the world Sangers sequencing services market share analysis, 2017

CHAPTER 5: GLOBAL SANGERS SEQUENCING SERVICE MARKET, BY APPLICATION

5.1. Overview

5.1.1. Market size and forecast

5.2. Diagnostics

5.2.1. Market size and forecast, by region
5.2.2. Market analysis, by region

5.3. Biomarkers & cancer

5.3.1. Market size and forecast, by region
5.3.2. Market analysis, by region

5.4. Reproductive health

5.4.1. Market size and forecast, by region
5.4.2. Market analysis, by region

5.5. Personalized medicine

5.5.1. Market size and forecast, by region
5.5.2. Market analysis, by region

5.6. Forensics

5.6.1. Market size and forecast, by region
5.6.2. Market analysis, by region

5.7. Others

5.7.1. Market size and forecast, by region
5.7.2. Market analysis, by region

CHAPTER 6: GLOBAL SANGERS SEQUENCING SERVICE MARKET, BY END USER

6.1. Overview

6.1.1. Market size and forecast

6.2. Academic & government research institutes

6.2.1. Market size and forecast, by region
6.2.2. Market analysis, by region

6.3. Pharmaceutical companies

6.3.1. Market size and forecast, by region
6.3.2. Market analysis, by region

6.4. Biotechnology companies

6.4.1. Market size and forecast, by region
6.4.2. Market analysis, by region

6.5. Hospitals & clinics

6.5.1. Market size and forecast, by region
6.5.2. Market analysis, by region

CHAPTER 7: GLOBAL SANGERS SEQUENCING SERVICE MARKET, BY REGION

7.1. OVERVIEW

7.1.1. Market size and forecast

7.2. U.S.

7.2.1. Key market trends
7.2.2. U.S. market size and forecast

7.2.2.1. U.S. Sangers sequencing service market, by application
7.2.2.2. U.S. Sangers sequencing service market, by end user

7.3. Europe

7.3.1. Key market trends
7.3.2. Europe market size and forecast

7.3.2.1. Europe Sangers sequencing service market, by application
7.3.2.2. Europe Sangers sequencing service market, by end user

7.4. Japan

7.4.1. Key market trends
7.4.2. Japan market size and forecast

7.4.2.1. Japan Sangers sequencing service market, by application
7.4.2.2. Japan Sangers sequencing service market, by end user

7.5. China

7.5.1. Key market trends
7.5.2. China market size and forecast

7.5.2.1. China Sangers sequencing service market, by application
7.5.2.2. China Sangers sequencing service market, by end user

7.6. India

7.6.1. Key market trends
7.6.2. India market size and forecast

7.6.2.1. India Sangers sequencing service market, by application
7.6.2.2. India Sangers sequencing service market, by end user

7.7. Southeast Asia

7.7.1. Key market trends
7.7.2. Southeast Asia market size and forecast

7.7.2.1. Southeast Asia Sangers sequencing service market, by application
7.7.2.2. Southeast Asia Sangers sequencing service market, by end user

7.8. Rest of the world

7.8.1. Key market trends
7.8.2. Rest of the world market size and forecast

7.8.2.1. Rest of the world Sangers sequencing service market, by application
7.8.2.2. Rest of the world Sangers sequencing service market, by end user

CHAPTER 8: COMPANY PROFILES

8.1. CeMIA SA

8.1.1. Company Profile
8.1.2. Main business/business overview
8.1.3. Products, services, and solutions
8.1.4. CeMIA Revenue (Million USD)

8.2. Fasteris SA

8.2.1. Company Profile
8.2.2. Main business/business overview
8.2.3. Products, Services, and Solutions
8.2.4. Fasteris revenue (million USD)

8.3. GENEWIZ, Inc.

8.3.1. Company Profile
8.3.2. Main business/business overview
8.3.3. Products, services, and solutions
8.3.4. GENEWIZ Revenue (Million USD)
8.3.5. Recent developments

8.4. GenHunter Corporation

8.4.1. Company Profile
8.4.2. Main business/business overview
8.4.3. Products, Services, and Solutions
8.4.4. GenHunter revenue (million USD)

8.5. Genscript Biotech Corporation

8.5.1. Company Profile
8.5.2. Main Business/Business Overview
8.5.3. Products, Services, and Solutions
8.5.4. GenScript revenue (million USD)

8.6. LGC Science Group Holdings Limited

8.6.1. Company Profile
8.6.2. Main Business/Business Overview
8.6.3. Products, Services, and Solutions
8.6.4. LGC revenue (million USD)
8.6.5. Recent developments

8.7. Microsynth AG

8.7.1. Company Profile
8.7.2. Main business/business overview
8.7.3. Products, Services, and Solutions
8.7.4. Microsynth revenue (million USD)

8.8. Nucleics Pty. Ltd.

8.8.1. Company Profile
8.8.2. Main Business/Business Overview
8.8.3. Products, Services, and Solutions
8.8.4. Nucleics revenue (million USD)

8.9. Quintara Biosciences

8.9.1. Company Profile
8.9.2. Main Business/Business Overview
8.9.3. Products, Services, and Solutions
8.9.4. Quintara revenue (million USD)
8.9.5. Recent Developments

8.10. SciGenom Labs Pvt. Ltd.

8.10.1. Company Profile
8.10.2. Main business/business overview
8.10.3. Products, Services, and Solutions
8.10.4. SciGenom Labs revenue (million USD)

8.11. Source BioScience Plc

8.11.1. Company Profile
8.11.2. Main business/business overview
8.11.3. Products, services, and solutions
8.11.4. Source BioScience revenue (million USD)

8.12. Thermo Fisher Scientific Inc.

8.12.1. Company Profile
8.12.2. Main business/business overview
8.12.3. Products, services, and solutions
8.12.4. Thermo Fisher revenue (million USD)
8.12.5. Recent developments